In our practice, constipation is one of the most consistently reported problems on GLP-1 therapy, particularly in the first weeks of a new dose
Many candidates also experience persistent cravings, insulin resistance, or metabolic slowdown that GLP-1 therapy may help address
Yes, there is no absolute contraindication to using GLP-1 receptor agonists with Hashimoto's disease
If brand-name is not an option, reputable compounding through a licensed provider like Peak Wellness offers a pragmatic alternative, with the understanding that you are accepting a different risk profile
30 Semaglutide A systematic review and meta-analysis of injectable or oral semaglutide for type 2 diabetes mellitus found no evidence of increased incidence of acute pancreatitis
GLP-1 (Glucagon-like Peptide-1) medications are a class of drugs used primarily to treat type 2 diabetes and, in some cases, to aid weight loss